TY - JOUR
T1 - What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management
AU - Bailey, Clifford J
AU - Blonde, Lawrence
AU - Del Prato, Stefano
AU - Leiter, Lawrence A
AU - Nesto, Richard
PY - 2009/10
Y1 - 2009/10
N2 - The Global Partnership for Effective Diabetes Management was established in 2004 to provide practical guidance to improving glycaemic control for people with type 2 diabetes. Those recommendations have been updated to take account of recent trials assessing the effects of intensive glucose control. We continue to emphasis the importance of early and sustained glycaemic control, aiming for HbA( 1c) 6.5-7% wherever safe and appropriate. Individualisation of targets and the management process is strongly encouraged to accommodate patient circumstances and to avoid hypoglycaemia. Prompt introduction of combinations of agents is suggested when monotherapy is inadequate.Treatments will preferably address the underlying pathophysiology of type 2 diabetes and integrate within a wider programme of care which also aims to reduce modifiable cardiovascular risk factors and better equip patients in the self-management of their condition.
AB - The Global Partnership for Effective Diabetes Management was established in 2004 to provide practical guidance to improving glycaemic control for people with type 2 diabetes. Those recommendations have been updated to take account of recent trials assessing the effects of intensive glucose control. We continue to emphasis the importance of early and sustained glycaemic control, aiming for HbA( 1c) 6.5-7% wherever safe and appropriate. Individualisation of targets and the management process is strongly encouraged to accommodate patient circumstances and to avoid hypoglycaemia. Prompt introduction of combinations of agents is suggested when monotherapy is inadequate.Treatments will preferably address the underlying pathophysiology of type 2 diabetes and integrate within a wider programme of care which also aims to reduce modifiable cardiovascular risk factors and better equip patients in the self-management of their condition.
KW - biological markers
KW - blood glucose
KW - cooperative behavior
KW - type 2 diabetes mellitus
KW - combination drug therapy
KW - evidence-based medicine
KW - glycosylated hemoglobin A
KW - humans
KW - hypoglycemia
KW - hypoglycemic agents
KW - individualized medicine
KW - international cooperation
KW - practice guidelines as topic
KW - treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=70350152739&partnerID=8YFLogxK
UR - http://dvr.sagepub.com/content/6/4/283
U2 - 10.1177/1479164109341691
DO - 10.1177/1479164109341691
M3 - Article
C2 - 20368223
SN - 1479-1641
VL - 6
SP - 283
EP - 287
JO - Diabetes and Vascular Disease Research
JF - Diabetes and Vascular Disease Research
IS - 4
ER -